Skip to main content
. 2011 Mar 1;76(9):795–800. doi: 10.1212/WNL.0b013e31820e7b8d

Table 2.

Clinical features and outcome of patients with positive GABABR-ab

graphic file with name znl00911-8569-t02.jpg

Abbreviations: BRSK2 = brain serine/threonine kinase 2; GABABR-ab = γ-aminobutyric acid-B receptor antibodies; GAD = glutamic acid decarboxylase; IVIg = IV immunoglobulin; SCLC = small-cell lung cancer; WBC = white blood cells.

a

Predominant symptom listed first.

b

Recovery before the start of chemotherapy.

c

Patients previously reported in references 10 and 9.

d

Included in the initial series of GABAR-ab.4